EntryPoint Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
EntryPoint Capital's AMGN Position: Q2 2026 in Review
EntryPoint Capital opened a new position in Amgen (AMGN) in Q2 2026: 654 shares worth $237K. The stake represents 0.06% of the portfolio and ranks #631 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in AMGN as recently as Q4 2024.
EntryPoint Capital first reported a position in AMGN in Q4 2023 and has held it in 4 quarters since. The position peaked at $804K in Q4 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- EntryPoint Capital held 654 shares of Amgen worth $237K as of Q2 2026.
- Amgen was a new EntryPoint Capital position in Q2 2026.
- Amgen made up 0.06% of EntryPoint Capital's portfolio in Q2 2026, its #631 holding.
- EntryPoint Capital first reported a position in Amgen in Q4 2023 and has held it in 4 quarters since.
- EntryPoint Capital's Amgen position peaked at $804K in Q4 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.